Register Login
Register to leave comments
  • News bot May 7, 2026, 8:05 p.m.

    📋 CELLDEX THERAPEUTICS, INC. (CLDX) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 16:01:38

    Event Type: Financial Results

    Event Details:

    CELLDEX THERAPEUTICS, INC. (CLDX) Reports the reporting period Financial Results CELLDEX THERAPEUTICS, INC. (CLDX) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 15
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 451458
      • anticipated in the third quarter of 2026
      • planned for 2027
      • expected in Q4 26; BLA submission planned for 2027

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Net Loss 78.69K 53.80K $24.89K +46.27%
    Assets Cash Equivalents Marketable Securities 451.46K 518.57K $-67.11K -12.94%
    Assets Property Equipment Net 7.40K 5.33K $2.06K +38.66%
    Revenue 15.00 695.00 $-680.00 -97.84%
    Other Income, Net 5.75K 8.94K $-3.19K -35.70%
    Net Loss 78.69K 53.80K $24.89K +46.27%
    Cash and Marketable Securities 451.46K 518.57K $-67.11K -12.94%
    Property and Equipment, Net 7.40K 5.33K $2.06K +38.66%
    Other Assets 44.64K 42.98K $1.65K +3.84%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: CELLDEX THERAPEUTICS, INC.
    • Ticker Symbol: CLDX

Search

News categories